Serum Vascular Endothelial Growth Factor Levels before and after Intravitreous Ranibizumab Injection for Retinopathy of Prematurity

BACKGROUND: Retinopathy of prematurity (ROP) is one of the common complications of prematurity. Intravitreal injection of ranibizumab (IVR), an antivascular endothelial growth factor (VEGF) drug, showed significant benefit for ROP. However, there are concerns about systemic complications of anti-VEG...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Ophthalmol
मुख्य लेखकों: Chen, Xuting, Zhou, Lin, Zhang, Qi, Xu, Yu, Zhao, Peiquan, Xia, Hongping
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Hindawi 2019
विषय:
Clinical Study
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6545787/
https://ncbi.nlm.nih.gov/pubmed/31236289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/2985161
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन